⚠️ Uptrend Under Pressure Severe risk · 99 · Institutional selling is building — 6 distribution days in the last 25 sessions. · 6 distribution days (SPY) Full briefing → Jul 28
Simple research view

TFX · Teleflex Incorporated

$131.05 latest stored close
Detected setup Flat Base

Watch · Quality 22/100

Ask about TFX

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

Scans / Health Technology / TFX

$TFX

Teleflex Incorporated

Teleflex Incorporated is a mid-cap Medical Specialties company in the Health Technology sector with a market cap of $6B.

Neutral · 53 Health Technology Medical Specialties stock Stage 2 · Advancing Base 2 Data 1h 58m ago
$131.05 latest close
Council read · 6 methods

Watch — evidence is building

0 buyable · 5 watch · 1 avoid. Review the observed passes and blockers before reading the chart.

Earnings-risk mode

Pre-earnings setup

Thursday, July 30, 2026 Time not confirmed No sourced report session or clock time

Deterministic evidence

TFX-0.79%
Sector proxy · XLV+0.51%
Broad market · SPY+0.02%
Same completed session window ending 2026-07-27. TFX was -1.30 points vs XLV. -0.81 points vs SPY.
CatalystUnavailable Stock reactionNegative Sector reactionSupportive Opening surgeUnavailable Event riskEarnings-driven
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

AI interpretation (optional)

Ask a Legend to interpret the evidence only after reviewing the deterministic event timing and relative reaction.

Interpret this evidence AI output is commentary, not scanner evidence or a sizing recommendation.
Price $131.05 Jul 27 close
52W High $139.67 -6.2%
52W Low $100.18
Wks Since High 13w
Base Depth -15.1%
Base B2
SMA 50 $130.76
SMA 200 $120.91
Avg Vol 523,122
RS Rank 16
RS vs High -12.2%
RS Slope +3.1% ▲
Grp Rank #48/64
ADR% 2.9%
ATR(14) $4.31 (3.3%)
Rel Vol (today) 0.83×
Vol Pace N/A
U/D Vol 1.01
A/D Days 19A / 20D
A/D Rating D
VDU Bars 0/10 d
Earnings 2d
$100.18
$139.67 78%

TFX Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for TFX.

Create Free Account
Setup Quality C 3/7 signals
Jul 24: 56 (Trend Only)Jul 24: 56 (Trend Only)Jul 27: 55 (Flat Base)Jul 28: 55 (Flat Base)55 Score trend
✓ Stage 2 · Advancing ✗ Power Trend ✗ RS New High ✓ Trend 7/8 ✗ No Pattern ✗ CANSLIM 46.3 (D) ✓ Gatekeeper Base #2 (B)

See the full conviction stack.

Unlock Insights

Technical Analysis Report Card

$TFX · $131.05 · as of 2026-07-27 · multi-factor read
53
/ 100
Neutral

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating
Weekly ▬ Sideways / consolidating
Monthly ▲ Uptrend

Moving Averages

50-day$130.76 ↑
100-day$125.58 ↑
200-day$120.91 ↑
Bullish (50 > 200)

RSI (14)

Reading48.4 · Neutral

Neutral — momentum is balanced between buyers and sellers.

MACD (12/26/9)

StateWeakening
Histogram-0.344

Weakening — MACD slipped below its signal line. Histogram contracting.

Bollinger Bands (20,2)

%B / Width36% · 8.2%
Squeeze — volatility compressing

Mid-band — no directional band edge in play. Bands are squeezing — volatility is compressing, often a precursor to a sharp move.

Volume · Buyer vs Seller

Up/Down vol1.01 · Neutral
Rel volume0.83×

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $136.29swing level
R · $139.4352-week high
Price · $131.05now
S · $128.01swing level
S · $124.49swing level
S · $120.86swing level

Fibonacci · Uptrend swing

23.6% ◄ price here$130.70
38.2%$125.15
50.0%$120.66
61.8%$116.17
78.6%$109.79

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for TFX — plus the full 495-symbol scanner and Ask-the-Legends chat.
🔒 Start your 7-day free trial →
Monthly uptrendAbove 200-day MA50/200 bullishRS 16 (laggard)
Want this read in a legend's voice? 💬 Ask a Legend about TFX
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 🟡 5 of 6 legends are Watching — building, not yet a confirmed buy.
Watch
Minervini C

Trend-template read: 8/12 pass; wait for the soft misses to improve.

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $131.05, MA150 $121.10, MA200 $120.91
1.2 150-day MA > 200-day MAMA150 $121.10 vs MA200 $120.91
Failing evidence
1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 16
2. Quarterly EPS growth ≥ 25%-28.0% QoQ
8/12 checks
Avoid
O'Neil D

CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence
N: Near 52-week high or RS line new high6.2% below high | RS line new high: False
S: Base tightness (ATR% ≤ 4.5%)ATR% 3.29%
Failing evidence
C: Quarterly EPS acceleration ≥ 25%-28.0% QoQ
L: RS rank ≥ 80 (IBD leadership)RS rank 16
2/8 checks
Watch
Weinstein C

Stage-analysis read: Stage 2 is present; 3 supporting checks need improvement.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $131.05 vs MA200 $120.91
Failing evidence
Volume expansion above averageVolume ratio 0.83x
Relative strength ≥ 60RS 16
4/7 checks
Watch
Livermore B

Pivotal-point read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$131.05
Distance from 52-week high6.2% below high
Failing evidence
Relative strengthRS 16
Volume vs average0.83x
3/6 checks
Watch
Darvas B

Box-theory read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$131.05
Distance from 52-week high6.2% below high
Failing evidence
Relative strengthRS 16
Volume vs average0.83x
3/6 checks
Watch
Wyckoff B

Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$131.05
Distance from 52-week high6.2% below high
Failing evidence
Relative strengthRS 16
Volume vs average0.83x
3/6 checks
Breakout Health

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising
98RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +6 D
A: 18 D: 12 Net: +665 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini SEPA criteria · 3/7 met
C 3/7 SEPA
Separate score from the 8-point Trend Template (7/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ -28%
Revenue growth ≥20% YoY +17%
Gross margin ≥30% 53%
ROE ≥17% -28%
RS rating ≥80 (leadership) 16
Stage 2 uptrend (Weinstein) Stage 2
Within 25% of 52W high -6.2%

Method Playbook

📋 Trade it like O'Neil EXACT LEVELS · PRO
Minervini O'Neil Livermore Weinstein Darvas Wyckoff
O'Neil D · Avoid — The deterministic methodology check is Avoid; wait until the blocking criteria are resolved.
Pivot
Pro level
Published-method rule: Use the proper base pivot or handle high after CANSLIM leadership and market-direction checks are satisfied.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a breakout through the pivot on volume at least 40% above average; the valid buy zone ends 5% above the pivot.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Use the setup's structural stop with a hard 7–8% maximum-loss ceiling from the actual entry.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Protect progress under constructive support such as the 21-day or 10-week line; a stop may ratchet higher but never lower.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit on the hard loss limit, a decisive support break, or a rule-based climax/distribution signal; a normal 20–25% advance is reviewed rather than assumed permanent.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →
The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →

Pattern Analysis

Flat Base ⚠ Not actionable yet
55.0 score
RS Score 16
Trend 7/8
CANSLIM 46.3* (D)
depth pct: 13.2 base days: 35 prior uptrend pct: 35.0 weekly close spread pct: 7.1 vol dried: ✓ validation reason: valid generic setup multi tf evaluated: ✓ multi tf reason: weekly trend template 7/8 confirmed
Why This Setup? D+W Confluence
Flat Base

Flat Base: 35d base, depth 13.2%, prior uptrend 35%. Pivot $139.18. | Strong trend (7/8) | Moderate pattern (65%) | Stage 2 | Readiness 55/100 (early) | CANSLIM 46.3 (D) | ⚠ Not actionable yet

The Universal Edge Check

The panel is uneasy

Too many universals unmet — this leans closer to a guess than a trade.

1/7 universals met
Why these seven? → The Universal Edge

Minervini Trend Template

7/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $131.05 vs SMA150 $121.10 / SMA200 $120.91
SMA 150 above SMA 200 SMA150 $121.10 vs SMA200 $120.91
SMA 200 trending up Slope +0.75 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $130.76
Price above SMA 50 $131.05 vs SMA50 $130.76
30%+ above 52W low +30.8% from $100.18
Within 25% of 52W high -6.2% from $139.67
RS score above 70 RS 16

Fundamentals

52W Range
78%
Mkt Cap SEC
5.8B
EPS QoQ
-28%
Rev YoY
+17%
ROE
-28%
Gross Margin
53%
D/E
0.85
EPS TTM
$-20.25
Float
44M
Insider
No Buy

Company

Legend AI snapshot
Teleflex Incorporated
TFX · NYSE · Health Technology · Medical Specialties
$131.05latest close $5.8Bmarket cap 16RS rank 55setup score
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
D 46.3* CANSLIM * disqualified on C, M
C · Curr. EPS
20
A · Annual EPS
46
N · New Highs
100
S · Supply/Demand
70
L · Leader RS
16
I · Inst. Spons.
56
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
7/8
W. RS
67
W. Support
$101.65
W. Resist
$139.67
W. Patterns
Basing
Weekly Structure

Scan History

20× streak
Jul 24: 56 (Trend Only)Jul 24: 56 (Trend Only)Jul 27: 55 (Flat Base)Jul 28: 55 (Flat Base)55
Jul 28
Flat Base ✓ Gate
55
Jul 27
Flat Base ✓ Gate
55 0.0%
Jul 24
Trend Only ✓ Gate
56 -0.8%
Jul 24
Trend Only ✓ Gate
56 -0.8%

Get the full picture on TFX

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 495+ symbols daily.

Start 7-Day Free Trial